Pharmacology, Toxicology and Pharmaceutical Science
1,1 Diphenyl 2 Picrylhydrazyl
33%
1,2-Dimethylhydrazine
60%
Aberrant Crypt Foci
20%
Alpha Glucosidase
6%
Andrographolide
100%
Anticarcinogen
7%
Antiinfective Agent
7%
Antimicrobial Agent
33%
Antioxidant
33%
Antioxidant Capacity
13%
Candida parapsilosis
6%
Catalase
20%
Cetuximab
100%
Chitosan
100%
Chitosan Nanoparticle
66%
Chronic Disease
6%
Cisplatin
7%
Colon Carcinoma
20%
Colorectal Carcinoma
100%
Cytotoxicity
66%
Diseases
6%
Epidermal Growth Factor Receptor
13%
Flower Extract
13%
Fourier Transform Infrared Spectroscopy
14%
Free Radical
6%
Glucan 1,4 Alpha Glucosidase
6%
Guava
66%
Hydrogen Peroxide
13%
Hydroxyl Radical
6%
IC50
14%
Malignant Neoplasm
54%
Mortality Rate
7%
Nanocarrier
20%
Nanoparticle
100%
Nitric Oxide
20%
Non-Competitive Inhibition
6%
Pectin
33%
Protein Bcl 2
7%
Receptor
20%
Side Effect
7%
Sucrase Isomaltase
6%
Sulfonic Acid
20%
Systemic Disease
6%
Treatment Group
40%
Triple Negative Breast Cancer
66%
Tumor Suppressor Protein
7%
Zinc Oxide Nanoparticle
33%
Biochemistry, Genetics and Molecular Biology
Acridine Orange
33%
Alpha-Glucosidase
16%
Antibacterial Activity
33%
Antidiabetic Activity
66%
Antimicrobial Activity
66%
Antineoplastic Activity
66%
Cell Viability
33%
DNA Fragmentation
33%
Enzyme
33%
Escherichia coli
33%
Ethidium Bromide
33%
Glucosidase
16%
Green Synthesis
66%
IC50
66%
Klebsiella pneumoniae
33%
Koji
33%
Maltase
33%
Medicinal Plant
33%
Phytochemical
33%
Plant Extract
33%
Programmed Cell Death
33%
Scanning Electron Microscopy
33%
Staphylococcus aureus
33%
Sucrase-Isomaltase
33%
Medicine and Dentistry
Adverse Event
8%
Antioxidant
33%
Antioxidant Capacity
13%
Catalase
20%
Cell Damage
6%
Cervicogenic Headache
66%
Chronic Disease
6%
Clinical Study
5%
Diseases
6%
DPPH
33%
Flower Extract
13%
Hydrogen Peroxide
13%
In Vitro
33%
Magnetic Resonance Imaging
66%
Malignant Neoplasm
6%
Mixed Model
5%
Neck Disability Index
10%
Nitric Oxide
20%
Oxidative Stress
20%
Pain Threshold
10%
Physiotherapy
35%
Placebo
66%
Pulse Rate
8%
Quality of Life
40%
Randomized Controlled Trial
66%
Range of Motion
25%
Resistance Training
8%
Side Effect
8%
Sulfonic Acid Derivative
20%
Systemic Disease
6%
Therapeutic Agent
6%
Treatment Group
5%
Visual Analog Scale
8%